Madrigal Pharmaceuticals Inc
NASDAQ:MDGL

Watchlist Manager
Madrigal Pharmaceuticals Inc Logo
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL
Watchlist
Price: 562.73 USD -1.52% Market Closed
Market Cap: 12.8B USD

Wall Street
Price Targets

MDGL Price Targets Summary
Madrigal Pharmaceuticals Inc

Wall Street analysts forecast MDGL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MDGL is 573.11 USD with a low forecast of 460.56 USD and a high forecast of 682.5 USD.

Lowest
Price Target
460.56 USD
18% Downside
Average
Price Target
573.11 USD
2% Upside
Highest
Price Target
682.5 USD
21% Upside
Madrigal Pharmaceuticals Inc Competitors:
Price Targets
MRSN
Mersana Therapeutics Inc
19% Upside
GLTO
Galecto Inc
2% Upside
BMRN
Biomarin Pharmaceutical Inc
78% Upside
RNA
Avidity Biosciences Inc
3% Upside
IMNM
Immunome Inc
12% Upside
301080
Acrobiosystems Co Ltd
43% Upside
300685
Amoy Diagnostics Co Ltd
41% Upside
ARWR
Arrowhead Pharmaceuticals Inc
15% Downside

Revenue
Forecast

Revenue Estimate
Madrigal Pharmaceuticals Inc

For the last 13 years the compound annual growth rate for Madrigal Pharmaceuticals Inc's revenue is 28%. The projected CAGR for the next 4 years is 102%.

28%
Past Growth
102%
Estimated Growth
Estimates Accuracy
2%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Madrigal Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Madrigal Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-42%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MDGL's stock price target?
Price Target
573.11 USD

According to Wall Street analysts, the average 1-year price target for MDGL is 573.11 USD with a low forecast of 460.56 USD and a high forecast of 682.5 USD.

What is Madrigal Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
102%

For the last 13 years the compound annual growth rate for Madrigal Pharmaceuticals Inc's revenue is 28%. The projected CAGR for the next 4 years is 102%.

Back to Top